ProQR Remains Confident In Pipeline After Sepofarsen Flop, Analysts Not So Much

 
• By Alaric DeArment
  
Eye
ProQR said its Phase II/III trial of sepofarsen in LBA10 failed • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Sensory

More from Therapeutic Category